...
首页> 外文期刊>Vascular and endovascular surgery >Controversies in the management of type II 'branch' endoleaks following endovascular abdominal aortic aneurysm repair.
【24h】

Controversies in the management of type II 'branch' endoleaks following endovascular abdominal aortic aneurysm repair.

机译:血管内腹主动脉瘤修复后II型“分支”内漏的治疗争议。

获取原文
获取原文并翻译 | 示例
           

摘要

Successful endovascular aortic aneurysm repair (EVAR) is often defined as complete exclusion of blood flow within the aneurysm sac. Perigraft flow, also known as endoleak, is the most common complication following EVAR. Attachment site related endoleaks (type I) are generally considered to warrant some form of intervention due to the belief that they represent a risk for future rupture. Management of type II endoleaks, also known as branch or collateral endoleaks, is more controversial. Some advocate a policy of watchful-waiting whereas others treat all type II endoleaks as soon as they are discovered. The following review explores the controversies pertaining to the management, diagnosis and surveillance imaging, and treatment of type II endoleaks.
机译:成功的血管内主动脉瘤修复(EVAR)通常被定义为完全排除动脉瘤囊内的血流。移植后血流,也称为内漏,是EVAR之后最常见的并发症。与附着位点相关的内漏(I型)通常被认为需要某种形式的干预,因为他们认为它们代表将来破裂的风险。 II型内漏(也称为分支或旁侧内漏)的管理更具争议性。有些人提倡警惕等待的政策,而另一些人则一发现所有II型内漏就立即处理。以下评论探讨了与II型内漏的管理,诊断和监视影像以及治疗有关的争议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号